194 related articles for article (PubMed ID: 26561336)
1. Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
Shao B; Wei X; Luo M; Yu J; Tong A; Ma X; Ye T; Deng H; Sang Y; Liang X; Ma Y; Wu Q; Du W; Du J; Gao X; Wen Y; Fu P; Shi H; Luo S; Wei Y
Sci Rep; 2015 Nov; 5():16437. PubMed ID: 26561336
[TBL] [Abstract][Full Text] [Related]
2. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
4. A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation.
Wei P; Cui G; Lu Q; Yang L; Guan Z; Sun W; Zhao Y; Wang S; Peng Q
Vet Microbiol; 2015 Jan; 175(1):50-7. PubMed ID: 25433453
[TBL] [Abstract][Full Text] [Related]
5. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
6. TNF signaling drives myeloid-derived suppressor cell accumulation.
Zhao X; Rong L; Zhao X; Li X; Liu X; Deng J; Wu H; Xu X; Erben U; Wu P; Syrbe U; Sieper J; Qin Z
J Clin Invest; 2012 Nov; 122(11):4094-104. PubMed ID: 23064360
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.
Braun FC; van den Brandt J; Thomas S; Lange S; Schrank J; Gand C; Przybylski GK; Schmoeckel K; Bröker BM; Schmidt CA; Grabarczyk P
PLoS One; 2015; 10(9):e0135444. PubMed ID: 26327508
[TBL] [Abstract][Full Text] [Related]
9. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.
Lesokhin AM; Hohl TM; Kitano S; Cortez C; Hirschhorn-Cymerman D; Avogadri F; Rizzuto GA; Lazarus JJ; Pamer EG; Houghton AN; Merghoub T; Wolchok JD
Cancer Res; 2012 Feb; 72(4):876-86. PubMed ID: 22174368
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
11. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
Huang HL; Yeh WC; Lai MZ; Mirtsos C; Chau H; Chou CH; Benchimol S
Br J Cancer; 2009 Nov; 101(9):1555-64. PubMed ID: 19826422
[TBL] [Abstract][Full Text] [Related]
12. Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the
Kobayashi M; Chung JS; Beg M; Arriaga Y; Verma U; Courtney K; Mansour J; Haley B; Khan S; Horiuchi Y; Ramani V; Harker D; Gopal P; Araghizadeh F; Cruz PD; Ariizumi K
Clin Cancer Res; 2019 Jan; 25(2):828-838. PubMed ID: 30049749
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
15. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
[TBL] [Abstract][Full Text] [Related]
17. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
18. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
Condamine T; Kumar V; Ramachandran IR; Youn JI; Celis E; Finnberg N; El-Deiry WS; Winograd R; Vonderheide RH; English NR; Knight SC; Yagita H; McCaffrey JC; Antonia S; Hockstein N; Witt R; Masters G; Bauer T; Gabrilovich DI
J Clin Invest; 2014 Jun; 124(6):2626-39. PubMed ID: 24789911
[TBL] [Abstract][Full Text] [Related]
19. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
20. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
